TONYA REID: Open Payments
NPI 1447631569 · GAFFNEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,364 in 147 payments from 37 companies in 2025. Trend: 2023 $2,417 · 2024 $3,876 · 2025 $3,364
Food & beverage: $3,143Education: $221
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 18 | $470 |
| AstraZeneca Pharmaceuticals LP | 10 | $259 |
| E.R. Squibb & Sons, L.L.C. | 12 | $230 |
| PFIZER INC. | 10 | $194 |
| Janssen Biotech, Inc. | 8 | $190 |
| SOBI, INC | 4 | $139 |
| Gilead Sciences, Inc. | 4 | $136 |
| Merck Sharp & Dohme LLC | 5 | $134 |
| TAIHO ONCOLOGY, INC. | 6 | $118 |
| ABBVIE INC. | 7 | $108 |
Products named: REBLOZYL, OPDIVO, OPDUALAG, Trodelvy, Doptelet, LONSURF, KEYTRUDA, Lenvima.
Industry payments across SC — which companies pay providers there.
